Ian Knemeyer

Merck & Co., Inc., Rahway, NJ, USA (United States)

Immunology and MicrobiologyMedicinePharmacology, Toxicology and PharmaceuticsNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin”.

In vivo bioluminescence imaging of labile iron in xenograft models and liver using FeAL-1, an iron-activatable form of D-luciferin

Cell chemical biology(2023)10.1016/j.chembiol.2023.09.006

N/A

0.424DataRank · unranked

7 citations

Honglin Jiang, Linh Tram, Cedric L. Hugelshofer, Oscar Ekpenyong, Ian Knemeyer +6 more